A wireless brain chip developed by Elon Musk’s company Neuralink hopes to begin mortal clinical trials in six months. Musk said that the new date was set after missing the former timeline set by the company.
The company is developing brain chip interfaces that can enable impaired cases to move and communicate again. It also aims to restore vision, Musk added.
Grounded on Bay Area and Austin in the San Francisco, Texas, Neuralink has been conducting tests on brutes in recent times as it seeks blessing from the US Food and Drug Administration (FDA) to begin clinical trials in humans.
” We want to be veritably careful and make sure it works well before we put the device on people,” Musk said during a important-awaited public update on the device.
Speaking to a select crowd of invited guests during a nearly three- hour donation at Neuralink’s headquarters, Musk emphasized the company’s pace of developing its device. “
At first progress, especially as it applies to humans, may feel sorrowfully slow, but we’re doing everything to resemblant it,” he added.
Musk said the first two mortal operations targeted by the Neuralink device will be restoring vision and enabling muscle movement in people who can not do so.